The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8 + T cells
Open accessAbstract
T cell receptor (TCR) down-modulation after antigen presentation is a fundamental process that regulates TCR signal transduction. Current understanding of this process is that intrinsic TCR/CD28 signal transduction leads to TCR down-modulation. Here, we show that the interaction between programmed cell death 1 ligand 1 (PD-L1) on dendritic cells (DCs) and programmed death 1 (PD-1) on CD8 T cells contributes to ligand-induced TCR down-modulation. We provide evidence that this occurs via Casitas B-lymphoma (Cbl)-b E3 ubiquitin ligase up-regulation in CD8 T cells. Interference with PD-L1/PD-1 signalling markedly inhibits TCR down-modulation leading to hyper-activated, proliferative CD8 T cells as assessed in vitro and in vivo in an arthritis model. PD-L1 silencing accelerates anti-tumour immune responses and strongly potentiates DC anti-tumour capacities, when combined with mitogen-activated kinase (MAPK) modulators that promote DC activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Self-citationWherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 2×
“590 are other pathways that inhibit effector T cell activities without modifying TCR levels (Barber et al, 2006; Choi & Schwartz, 2007; Wherry, 2011).”
BackgroundRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Curran, M. A., Montalvo, W., Yagita, H., & Allison, J. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915174107 · Cited by 1,874
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Serial triggering of many T-cell receptors by a few peptide–MHC complexes
Valitutti, S., Müller, S., Cella, M., Padovan, E., & Lanzavecchia, A. (1995) · Nature · doi:10.1038/375148a0 · Cited by 1,128
Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C., Flies, D. B., Lau, J. S., Zhu, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.1089.65.3 · Cited by 1,018
Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
Bachmaier, K., Krawczyk, C., Kozieradzki, I., Kong, Y.-Y., Sasaki, T., Oliveira-dos-Santos, A., Mariathasan, S., Bouchard, D., Wakeham, A., Itie, A., et al. (2000) · Nature · doi:10.1038/35003228 · Cited by 666
Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. K., Freeman, G. J., & Sharpe, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307252101 · Cited by 636
Cbl-b regulates the CD28 dependence of T-cell activation
Chiang, Y. J., Kole, H. K., Brown, K., Naramura, M., Fukuhara, S., Hu, R.-J., Jang, I. K., Gutkind, J. S., Shevach, E., & Gu, H. (2000) · Nature · doi:10.1038/35003235 · Cited by 621
Schönrich, G., Kalinke, U., Momburg, F., Malissen, M., Schmitt-Verhulst, A.-M., Malissen, B., Hämmerling, G. J., & Arnold, B. (1991) · Cell · doi:10.1016/0092-8674(91)90163-s · Cited by 506
TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity
Huppa, J. B., Axmann, M., Mörtelmaier, M. A., Lillemeier, B. F., Newell, E. W., Brameshuber, M., Klein, L. O., Schütz, G. J., & Davis, M. M. (2010) · Nature · doi:10.1038/nature08746 · Cited by 504
Functional Anatomy of T Cell Activation and Synapse Formation
Fooksman, D. R., Vardhana, S., Vasiliver-Shamis, G., Liese, J., Blair, D. A., Waite, J., Sacristán, C., Victora, G. D., Zanin-Zhorov, A., & Dustin, M. L. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101308 · Cited by 446
c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation
Naramura, M., Jang, I.-K., Kole, H., Huang, F., Haines, D., & Gu, H. (2002) · Nature Immunology · doi:10.1038/ni855 · Cited by 390
T‐cell tolerance or function is determined by combinatorial costimulatory signals
Nurieva, R., Thomas, S., Nguyen, T., Martin‐Orozco, N., Wang, Y., Kaja, M., Yu, X., & Dong, C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601146 · Cited by 245
Blockade of B7-H1 Suppresses the Development of Chronic Intestinal Inflammation
Kanai, T., Totsuka, T., Uraushihara, K., Makita, S., Nakamura, T., Koganei, K., Fukushima, T., Akiba, H., Yagita, H., Okumura, K., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4156 · Cited by 170
Hobo, W. A., Maas, F., Adisty, N., de Witte, T., Schaap, N. P., van der Voort, R., & Dolstra, H. (2010) · Blood · doi:10.1182/blood-2010-04-278739 · Cited by 167
Frecha, C., Costa, C., Nègre, D., Gauthier, E., Russell, S. J., Cosset, F.-L., & Verhoeyen, E. (2008) · Blood · doi:10.1182/blood-2008-05-155945 · Cited by 164
Holst, J., Wang, H., Eder, K. D., Workman, C. J., Boyd, K. L., Baquet, Z., Singh, H., Forbes, K., Chruscinski, A., Smeyne, R., et al. (2008) · Nature Immunology · doi:10.1038/ni.1611 · Cited by 163
CD4 T cells integrate signals delivered during successive DC encounters in vivo
Celli, S., Garcia, Z., & Bousso, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051018 · Cited by 159
Requirements for Peptide-induced T Cell Receptor Downregulation on Naive CD8+ T Cells
Cai, Z., Kishimoto, H., Brunmark, A., Jackson, M. R., Peterson, P. A., & Sprent, J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.641 · Cited by 158
Pilon‐Thomas, S., Mackay, A., Vohra, N. A., & Mulé, J. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904114 · Cited by 150
José, E. S., Borroto, A., Niedergang, F., Alcover, A., & Alarcón, B. (2000) · Immunity · doi:10.1016/s1074-7613(00)80169-7 · Cited by 145
HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7
Breckpot, K., Escors, D., Vargas, F. A., Lopes, L., Karwacz, K., Lint, S. V., Keyaerts, M., & Collins, M. K. (2010) · Journal of Virology · doi:10.1128/jvi.00014-10 · Cited by 139
Self-citationTargeting dendritic cell signaling to regulate the response to immunization
Escors, D., Lopes, L., Lin, R., Hiscott, J., Akira, S., Davis, R. J., & Collins, M. K. (2008) · Blood · doi:10.1182/blood-2007-11-122408 · Cited by 116
Self-citationMolecular mechanisms for adaptive tolerance and other T cell anergy models
Choi, S., & Schwartz, R. H. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.02.005 · Cited by 112
Essential Role of E3 Ubiquitin Ligase Activity in Cbl-b–Regulated T Cell Functions
Paolino, M., Thien, C. B. F., Gruber, T., Hinterleitner, R., Baier, G., Langdon, W. Y., & Penninger, J. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003390 · Cited by 100
Two Distinct Pathways Exist for Down-Regulation of the TCR
Lauritsen, J. P. H., Christensen, M., Dietrich, J., Kastrup, J., Ødum, N., & Geisler, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.260 · Cited by 88
Sierro, S. R., Donda, A., Perret, R., Guillaume, P., Yagita∥, H., Lévy, F., & Romero, P. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201041235 · Cited by 78
Vargas, F. A., Breckpot, K., Stephenson, H. N., Karwacz, K., Ehrenstein, M. R., Collins, M. K., & Escors, D. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30099 · Cited by 69
Self-citationZhou, Q., Xiao, H., Liu, Y., Peng, Y., Yuan, H., Yagita∥, H., Chandler, P., Munn, D. H., Mellor, A. L., Fu, N., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001821 · Cited by 62
Mirza, N. N., Correa, M. A. D., Dominguez, A. L., Schrum, A. G., Dong, H., & Lustgarten, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903561 · Cited by 50
Shamim, M. H., Nanjappa, S. G., Singh, A., Plisch, E. H., LeBlanc, S. E., Walent, J. H., Svaren, J. P., Seroogy, C. M., & Suresh, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7233 · Cited by 49
Membrane cell fusion activity of the vaccinia virus A17?A27 protein complex
Kochan, G. T., Escors, D., González, J. M., Casasnovas, J. M., & Estéban, M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01026.x · Cited by 39
Self-citationYang, S., Dudley, M. E., Rosenberg, S. A., & Morgan, R. A. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181e311cb · Cited by 34
Goold, H. D., Escors, D., Conlan, T., Chakraverty, R. K., & Bennett, C. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002529 · Cited by 29
Self-citationBreton, G., Yassine‐Diab, B., Cohn, L. B., Boulassel, M. R., Routy, J., Sékaly, R., & Steinman, R. M. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9313-9 · Cited by 26
Selden, C., Mellor, N., Rees, M., Laurson-Doube, J., Kirwan, M., Escors, D., Collins, M. K., & Hodgson, H. J. F. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1000 · Cited by 26
Self-citation
Cited by
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
“stimulatory signals on dendritic cells to further enhance their efficacy [92, 93].”
BackgroundHodi, F. S., Hwu, W.-J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0391 · Cited by 734
Extracellular vesicles in immunomodulation and tumor progression
Marar, C., Starich, B., & Wirtz, D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00899-0 · Cited by 584
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Xu-Monette, Z. Y., Zhou, J., & Young, K. H. (2018) · Blood · doi:10.1182/blood-2017-07-740993 · Cited by 433
PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Wu, Y., Chen, W., Xu, Z. P., & Gu, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02022 · Cited by 419
Metadata
- Authors
- Karwacz, K., Bricogne, C., MacDonald, D., Arce, F., Bennett, C. L., Collins, M., & Escors, D.
- Venue
- EMBO Molecular Medicine
- Published
- 2011-08-10
- Volume
- 3
- Issue
- 10
- Pages
- 581-592
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2097514222
- Cited by
- 265
- References
- 42
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.